Detalhe da pesquisa
1.
Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals.
Clin Gastroenterol Hepatol
; 17(10): 2050-2059.e1, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30471455
2.
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission.
Lancet Gastroenterol Hepatol
; 8(5): 458-492, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36871566
3.
Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn's Disease using Real-World Data.
J Crohns Colitis
; 14(4): 490-500, 2020 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630164
4.
The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
J Crohns Colitis
; 13(6): 744-754, 2019 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30916775
5.
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease.
Nat Med
; 25(4): 701, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846883
6.
Microbial network disturbances in relapsing refractory Crohn's disease.
Nat Med
; 25(2): 323-336, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30664783